triamcinolone acetonide has been researched along with eye in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (23.81) | 18.7374 |
| 1990's | 2 (4.76) | 18.2507 |
| 2000's | 19 (45.24) | 29.6817 |
| 2010's | 10 (23.81) | 24.3611 |
| 2020's | 1 (2.38) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, JM; Meyer, RF; Okumoto, M; Smolin, G | 1 |
| Cohn, BT; NAuheim, JS; Perry, HT | 1 |
| Kosar, K | 1 |
| Burns, RP; Tidwell, M | 1 |
| Orentreich, N; Selmanowitz, VJ | 1 |
| Esilä, R; Tarkkanen, A; Tenhunen, T | 1 |
| Chandler, D; Machemer, R; Schindler, RH; Thresher, R | 1 |
| Ellis, BD; Kosmorsky, GS | 1 |
| Degenring, RF; Jonas, JB; Kreissig, I | 1 |
| TOKUDA, H | 1 |
| HUGHES, WL; KAZDAN, MS; MARIS, CS | 1 |
| CHALKLEY, TH | 1 |
| Bleyl, U; Jonas, JB | 1 |
| Klais, CM; Spaide, RF | 1 |
| Degenring, R; Jonas, JB; Kreissig, I | 1 |
| Shimura, M; Shiono, T; Yasuda, K | 1 |
| Azad, RV; Pal, N | 1 |
| Cheng, L; Freeman, WR; Kosobucki, BR | 1 |
| Altintaş, O; Bardak, Y; Cekiç, O; Demirkol, A; Ekim, MM; Oyar, O; Tiğ, SU; Yeşildağ, A | 1 |
| Bauer, S; Feucht, N; Kotliar, K; Lanzl, I; Lohmann, C; Maier, M | 1 |
| Deren, YT; Gurelik, G; Hasanreisoglu, B; Ozdek, S | 1 |
| Cano, M; Chuck, RS; Gehlbach, PL; Mori, K; Nguyen, V; Park, CY; Parker, J; Yew, M | 1 |
| Bartz-Schmidt, KU; Heimann, H; Jaissle, GB; Kaczmarek, RT; Petermeier, K; Spitzer, MS; Szurman, P; Wong, D; Yoeruek, E | 1 |
| Kenney, MC; Kuppermann, BD; Mansoor, S | 1 |
| Ahmadi, F; Eghtedari, M; Hosseini, H; Mehryar, M; Nowroozizadeh, S | 1 |
| Nakazawa, T; Nishida, K; Sakamoto, T; Shimura, M; Shiono, T; Yasuda, K | 1 |
| Fang, W; Ying, F; Zhengyu, S | 1 |
| Behar-Cohen, F; Berdugo, M; Goumeaux, C; Houssier, M; Jeanny, JC; Savoldelli, M; Sennlaub, F; Torriglia, A; Valamanesh, F | 1 |
| Cavet, ME; López, FJ; Salvador-Silva, M; VanderMeid, KR; Ward, KW; Zhang, JZ | 1 |
| Asensio-Sánchez, VM; Conde, S; Jiménez-Prada, S; Martínez-Tellería, MJ; Soto, A | 1 |
| Araújo, J; Egea, MA; Garcia, ML; Gonzalez-Mira, E; Souto, EB | 1 |
| Chen, H; Cheng, L; Li, G; Li, Y; Luo, L; Nan, K; Qu, J; Sun, S | 1 |
| Cordero-Coma, M; Gallagher, MJ; Lavaque, AJ; Padula, WV; Yilmaz, T | 1 |
| Chen, H; Cheng, L; Du, W; Lan, B; Li, J; Sun, S; Xu, Y; Zhao, C | 1 |
| Christoforidis, J; Jiang, A; Joshi, M; Wang, J | 1 |
| Belfort, R; Caseli, L; Figueiredo, MC; Maia, M; Mota-Filipe, H; Rodrigues, E; Sa E Cunha, C; Sousa-Martins, D; Souza-Lima, A | 1 |
| Erdol, H; Hacioglu, D; Kola, M; Turk, A | 1 |
| Fujiwara, Y; Iwase, T; Ra, E; Terasaki, H; Ueno, Y; Yamamoto, K | 1 |
| Carfì Pavia, F; Cavallaro, G; Di Prima, G; Giammona, G; Licciardi, M; Lo Monte, AI | 1 |
| Katti, DS; Reddy, GB; Reddy, SS; Srinivasarao, DA | 1 |
| Baba, T; Oshitari, T; Takatsuna, Y; Tatsumi, T; Yamamoto, S | 1 |
4 review(s) available for triamcinolone acetonide and eye
| Article | Year |
|---|---|
Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.
Topics: Exudates and Transudates; Eye; Eye Diseases; Humans; Triamcinolone Acetonide; Vascular Diseases; Vitreous Body | 2005 |
Intraocular sustained-release delivery systems for triamcinolone acetonide.
Topics: Animals; Anti-Inflammatory Agents; Catheterization; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Drug Delivery Systems; Drug Implants; Eye; Eye Diseases; Humans; Injections; Microspheres; Triamcinolone Acetonide | 2009 |
Triamcinolone and intraocular sustained-release delivery systems in diabetic retinopathy.
Topics: Anti-Inflammatory Agents; Blood-Retinal Barrier; Delayed-Action Preparations; Diabetic Retinopathy; Drug Delivery Systems; Eye; Humans; Injections, Intraocular; Intravitreal Injections; Macular Edema; Randomized Controlled Trials as Topic; Triamcinolone; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Vitreous Body | 2011 |
Drug delivery implants in the treatment of vitreous inflammation.
Topics: Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antiviral Agents; Biocompatible Materials; Clinical Trials as Topic; Dexamethasone; Drug Delivery Systems; Eye; Fluocinolone Acetonide; Ganciclovir; Humans; Inflammation; Particle Size; Polymers; Prostheses and Implants; Ranibizumab; Triamcinolone Acetonide; Vitreous Body | 2013 |
2 trial(s) available for triamcinolone acetonide and eye
| Article | Year |
|---|---|
Posterior sub-Tenon's capsule injection of triamcinolone acetonide prevents panretinal photocoagulation-induced visual dysfunction in patients with severe diabetic retinopathy and good vision.
Topics: Aged; Connective Tissue; Diabetic Retinopathy; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Light Coagulation; Male; Middle Aged; Preoperative Care; Prospective Studies; Retina; Severity of Illness Index; Tomography, Optical Coherence; Triamcinolone Acetonide; Vision Disorders; Vision, Ocular | 2006 |
The effectiveness and reliability of posterior sub-Tenon triamcinolone acetonide injection in branch retinal vein occlusion-related macular edema.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Eye; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2016 |
36 other study(ies) available for triamcinolone acetonide and eye
| Article | Year |
|---|---|
Effect of pretreatment with local corticosteroids on antibody-forming cells in the eye and draining lymph nodes.
Topics: Adrenal Cortex Hormones; Animals; Antibody Formation; Antibody-Producing Cells; Eye; gamma-Globulins; Hemolytic Plaque Technique; Keratitis; Lymph Nodes; Rabbits; Triamcinolone; Triamcinolone Acetonide; Uveitis | 1975 |
Accidental intraocular injection with Dermojet syringe.
Topics: Adult; Eye; Humans; Iatrogenic Disease; Injections, Jet; Male; Triamcinolone Acetonide | 1977 |
Malformation spectra and embryolethality following intraamniotic administration of glucocorticoids in the chick embryo.
Topics: Abdominal Muscles; Abnormalities, Drug-Induced; Animals; Brain; Chick Embryo; Dexamethasone; Eye; Face; Hydrocortisone; Morphogenesis; Triamcinolone Acetonide | 1990 |
Experimental ocular malignant melanoma in Sinclair swine.
Topics: Animals; Conjunctiva; Eye; Eye Neoplasms; Injections; Melanoma; Neoplasm Transplantation; Pigmentation; Skin Neoplasms; Swine; Swine, Miniature; Triamcinolone Acetonide | 1986 |
Cutaneous corticosteroid injection and amaurosis. Analysis for cause and prevention.
Topics: Alopecia Areata; Blindness; Blood Pressure; Embolism; Eye; Female; Humans; Hydrocortisone; Injections, Intradermal; Male; Methylprednisolone; Ophthalmic Artery; Particle Size; Scalp; Suspensions; Triamcinolone Acetonide | 1974 |
Comparative evaluation of the topical antiphlogistic and ocular hypertensive activities of steroids in eye lotions.
Topics: Aminoisobutyric Acids; Animals; Betamethasone; Body Weight; Drug Evaluation, Preclinical; Eye; Intraocular Pressure; Male; Ophthalmic Solutions; Radiation Injuries, Experimental; Time Factors; Triamcinolone Acetonide; Ultraviolet Rays; Valerates | 1974 |
Ocular effects of long-term parenteral administration of triamcinolone. An experimental study on rabbits.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aqueous Humor; Ascorbic Acid; Aspartate Aminotransferases; Blood Cell Count; Blood Glucose; Blood Proteins; Blood Urea Nitrogen; Body Weight; Cataract; Cholesterol; Eosinophils; Eye; Fructose-Bisphosphate Aldolase; Intraocular Pressure; L-Lactate Dehydrogenase; Lens, Crystalline; Leukocytes; Potassium; Proteins; Rabbits; Triamcinolone Acetonide | 1967 |
The clearance of intravitreal triamcinolone acetonide.
Topics: Animals; Eye; Eye Diseases; Kinetics; Lens, Crystalline; Rabbits; Triamcinolone Acetonide; Vitreous Body | 1982 |
Referred ocular pain relieved by suboccipital injection.
Topics: Adult; Aged; Aged, 80 and over; Eye; Female; Humans; Injections, Subcutaneous; Lidocaine; Male; Middle Aged; Occipital Bone; Pain; Palliative Care; Triamcinolone Acetonide | 1995 |
Intravitreal triamcinolone acetonide as treatment of ischemic ophthalmopathy.
Topics: Aged; Anti-Inflammatory Agents; Eye; Humans; Injections; Intraocular Pressure; Iris; Ischemia; Male; Neovascularization, Pathologic; Ocular Hypotension; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body; Vitreous Hemorrhage; Waldenstrom Macroglobulinemia | 2003 |
[Effect of Kenacort-A ointment ophthalmic on ocular diseases].
Topics: Eye; Head; Ointments; Ophthalmology; Triamcinolone; Triamcinolone Acetonide | 1961 |
CLINICAL EXPERIENCE WITH OPHTHALMIC FORMULATIONS OF TRIAMCINOLONE ACETONIDE.
Topics: Drug Therapy; Eye; Eye Diseases; Humans; Inflammation; Neomycin; Ointments; Ophthalmic Solutions; Triamcinolone Acetonide; Tyrothricin | 1965 |
THE MANAGEMENT OF OCULAR INFLAMMATION WITH TRIAMCINOLONE ACETONIDE.
Topics: Drug Therapy; Eye; Eye Diseases; Head; Humans; Inflammation; Neomycin; Ointments; Ophthalmic Solutions; Triamcinolone Acetonide; Tyrothricin | 1965 |
Morphallaxia-like ocular histology after intravitreal triamcinolone acetonide.
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Eye; Female; Granulocytes; Humans; Injections, Intralesional; Macular Degeneration; Triamcinolone Acetonide | 2004 |
Intravitreal triamcinolone acetonide injection in ocular ischemic syndrome.
Topics: Aged; Eye; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injections; Ischemia; Macular Edema; Syndrome; Tomography, Optical Coherence; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2004 |
Posterior sub-Tenon's capsule triamcinolone.
Topics: Blepharoptosis; Connective Tissue; Eye; Humans; Injections; Orbital Diseases; Triamcinolone Acetonide | 2006 |
Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye.
Topics: Aged; Anti-Inflammatory Agents; Eye; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Photography; Prospective Studies; Pseudophakia; Survival Analysis; Triamcinolone Acetonide; Vitrectomy; Vitreous Body | 2006 |
Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.
Topics: Aged; Blood Flow Velocity; Diabetic Retinopathy; Diastole; Eye; Female; Glucocorticoids; Humans; Injections; Macular Edema; Male; Middle Aged; Ophthalmic Artery; Prospective Studies; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Resistance; Vitreous Body | 2007 |
Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model.
Topics: Aged; Biomechanical Phenomena; Eye; Female; Glucocorticoids; Humans; Injections; Intraocular Pressure; Male; Models, Biological; Paracentesis; Tonometry, Ocular; Triamcinolone Acetonide; Vitreous Body | 2007 |
Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.
Topics: Aged; Connective Tissue; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Laser Coagulation; Macular Edema; Male; Middle Aged; Retinal Vein Occlusion; Retrospective Studies; Tomography, Optical Coherence; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity; Vitreous Body | 2008 |
Periocular triamcinolone enhances intraocular gene expression after delivery by adenovirus.
Topics: Adenoviridae; Animals; Conjunctiva; Diagnostic Imaging; Eye; Gene Expression; Gene Transfer Techniques; Genetic Vectors; Glucocorticoids; Green Fluorescent Proteins; Injections; Luciferases, Firefly; Male; Mice; Mice, Inbred BALB C; Recombinant Fusion Proteins; Transgenes; Triamcinolone Acetonide; Vitreous Body | 2008 |
The distribution, release kinetics, and biocompatibility of triamcinolone injected and dispersed in silicone oil.
Topics: Cell Line; Cell Proliferation; Cell Survival; Enzyme-Linked Immunosorbent Assay; Eye; Glucocorticoids; Humans; Injections; Materials Testing; Microscopy, Electron, Scanning; Models, Biological; Retinal Ganglion Cells; Retinal Pigment Epithelium; Silicone Oils; Tissue Distribution; Triamcinolone Acetonide; Vitreous Body | 2009 |
Effect of intravitreal triamcinolone acetonide in the treatment of experimental Staphylococcus epidermidis endophthalmitis.
Topics: Animals; Disease Models, Animal; Endophthalmitis; Eye; Eye Infections, Bacterial; Glucocorticoids; Injections; Male; Rabbits; Staphylococcal Infections; Staphylococcus epidermidis; Treatment Outcome; Triamcinolone Acetonide; Vitreous Body | 2009 |
Drug reflux during posterior subtenon infusion of triamcinolone acetonide in diffuse diabetic macular edema not only brings insufficient reduction but also causes elevation of intraocular pressure.
Topics: Age Factors; Aged; Conjunctiva; Diabetic Retinopathy; Eye; Female; Fovea Centralis; Glucocorticoids; Humans; Injections; Intraocular Pressure; Macular Edema; Male; Middle Aged; Prospective Studies; Treatment Outcome; Triamcinolone Acetonide; Visual Acuity | 2009 |
Vehicle used for triamcinolone acetonide is toxic to ocular tissues of the pigmented rabbit.
Topics: Animals; Benzyl Alcohol; Carboxymethylcellulose Sodium; Ciliary Body; Cornea; Electroretinography; Eye; Female; Glucocorticoids; Injections; Intraocular Pressure; Lens, Crystalline; Male; Pharmaceutical Vehicles; Polysorbates; Rabbits; Retina; Triamcinolone Acetonide; Vitreous Body | 2009 |
Effects of triamcinolone acetonide on vessels of the posterior segment of the eye.
Topics: Animals; Apoptosis; Autophagy; Caspases; Cattle; Cell Proliferation; Cell Survival; Choroid; Corrosion Casting; Cyclooxygenase 2; Endothelial Cells; Epithelial Cells; Eye; Phagocytosis; Rats; Retina; Time Factors; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2009 |
BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.
Topics: Anti-Inflammatory Agents; Astrocytes; Benzofurans; Cell Extracts; Cells, Cultured; Conjunctiva; Dexamethasone; Endothelial Cells; Epithelial Cells; Epithelium, Corneal; Eye; Fibroblasts; Humans; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Interleukin-1beta; Lipopolysaccharides; Mitogen-Activated Protein Kinases; NF-kappa B; Optic Nerve; Pentanols; Phosphorylation; Quinolines; Receptors, Glucocorticoid; Triamcinolone Acetonide | 2009 |
[Retrobulbar triamcinolone injection and glycemic control].
Topics: Blood Glucose; Diabetes Mellitus; Eye; Female; Glucocorticoids; Humans; Injections; Male; Middle Aged; Triamcinolone Acetonide | 2009 |
Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
Topics: Administration, Topical; Angiogenesis Inhibitors; Animals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Dosage Forms; Drug Carriers; Drug Compounding; Eye; Glycerides; Lipids; Microscopy, Electron, Scanning; Models, Statistical; Nanostructures; Palmitic Acid; Particle Size; Polyethylenes; Polypropylenes; Rats; Spectroscopy, Fourier Transform Infrared; Squalene; Stearic Acids; Surface Properties; Surface-Active Agents; Technology, Pharmaceutical; Triamcinolone Acetonide; X-Ray Diffraction | 2010 |
Characterisation of systemic and ocular drug level of triamcinolone acetonide following a single sub-Tenon injection.
Topics: Animals; Eye; Glucocorticoids; Half-Life; Injections, Intraocular; Rabbits; Triamcinolone Acetonide | 2010 |
The effect of ocular pigmentation on transscleral delivery of triamcinolone acetonide.
Topics: Animals; Anti-Inflammatory Agents; Drug Delivery Systems; Eye; Eye Color; Melanins; Pigmentation; Rabbits; Retinal Pigments; Sclera; Triamcinolone Acetonide; Vitreous Body | 2013 |
Comparing the mode of action of intraocular lutein-based dyes with synthetic dyes.
Topics: Anterior Chamber; Basement Membrane; Coloring Agents; Epiretinal Membrane; Eye; Humans; Lutein; Membranes, Artificial; Models, Biological; Ophthalmic Solutions; Triamcinolone Acetonide; Vitreous Body | 2015 |
Effect of intravitreal or sub-tenon triamcinolone acetonide injection at completion of vitrectomy on peripheral retinochoroidal thickness in eyes with proliferative diabetic retinopathy.
Topics: Administration, Ophthalmic; Adult; Aged; Diabetic Retinopathy; Eye; Female; Humans; Intravitreal Injections; Male; Middle Aged; Retrospective Studies; Triamcinolone Acetonide; Vitrectomy | 2019 |
Microfibrillar polymeric ocular inserts for triamcinolone acetonide delivery.
Topics: Administration, Ophthalmic; Animals; Butylene Glycols; Cattle; Drug Implants; Drug Liberation; Eye; Glucocorticoids; Humans; Polymers; Triamcinolone Acetonide | 2019 |
Spatio-temporal control on the delivery of triamcinolone acetonide using polymeric nanoparticles reduces steroid induced cataract.
Topics: Administration, Ophthalmic; Animals; Biological Availability; Cadherins; Cataract; Coumarins; Diabetes Mellitus, Experimental; Drug Delivery Systems; Drug Liberation; Eye; Glucocorticoids; Male; Mice, Inbred C57BL; Poloxamer; Polyesters; Rats, Sprague-Dawley; Thiazoles; Triamcinolone Acetonide | 2019 |
Effects of Switching from Anti-VEGF Treatment to Triamcinolone Acetonide in Eyes with Refractory Macular Edema Associated with Diabetic Retinopathy or Retinal Vein Occlusion.
Topics: Aged; Cytokines; Diabetic Retinopathy; Eye; Female; Humans; Intraocular Pressure; Macular Edema; Male; Middle Aged; Recurrence; Retinal Vein Occlusion; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Visual Acuity | 2020 |